MEK1
6 drugs Oncology
4
approved indications
6
Approved Drugs
6
Companies
8
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (8 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Novartis 1 drug
Roche 1 drug
ARRAY BIOPHARMA INC 1 drug
By Therapeutic Area
Oncology 4 drugs
Other 2 drugs
By Therapeutic Area
Oncology 4 drugs
MEKINIST, COTELLIC, MEKTOVI, AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)
Other 2 drugs
KOSELUGO, GOMEKLI
Indications Treated
MelanomaNon-Small Cell Lung CancerAnaplastic Thyroid CancerSolid TumorsNeurofibromatosis Type 1Histiocytic NeoplasmsOvarian CancerPlexiform Neurofibroma